Report cover image

Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)

Publisher Kalorama Information
Published Apr 01, 2025
Length 285 Pages
SKU # KLI19997577

Description

Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)

The Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030) report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in new therapies and a promising pipeline, with significant clinical trial activity across various therapeutic areas, including oncology and cardiology.

This comprehensive report segments the market by therapeutic areas, providing detailed market estimates, forecasts, and insights into the competitive landscape. It covers global developments in cell, gene, and RNA therapy markets, focusing on key products, research trends, market breakdowns, regional revenues, and competitor analysis.

Key therapeutic areas covered include:
  • Oncology
  • Neurology
  • Musculoskeletal
  • Dermatology
  • Cardiology/Non-oncology blood
  • Other
The report excludes RNA therapies for COVID-19 and mRNA vaccines for infectious diseases, focusing instead on broader gene therapy applications. It also omits cord blood products, considering their classification as transplants.

Methodologically, the report combines primary and secondary research, including interviews with industry participants and comprehensive literature reviews. It provides market highlights, forecasts, and competitive analyses, discussing market indicators, trends, and barriers. Given the nascent stage of gene therapies, forecasts are based on limited precedents, with market size estimates provided for 2024 and projections through 2030.

This report serves as a crucial resource for understanding the evolving landscape of cell and gene therapies, offering valuable insights for stakeholders in the healthcare and biotechnology sectors.

Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030) is also the companion to another 2025 Kalorama Information report, Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition) , which provides an unparalleled deep dive into the CGT market’s financial ecosystem, covers financing, funding, partnering, M&A, tech transfers, IPOs/SPACs, and other deals.

Table of Contents

285 Pages
    • Overview
    • Scope and Methodology
    • Market Overview and Potential
    • Introduction
    • Cell Therapy
    • Gene Therapy
    • Cell and Gene Therapy: Characteristics
    • Staffing
    • Manufacturing Process for CAR-T
    • Cell and Gene Therapy Manufacturing Processes
    • Cost
    • Reimbursement
    • Logistics
    • Mergers and Acquisitions
    • Deals, Agreements, and Collaborations
    • Regulatory Developments
    • Pipeline, Development Overview
    • Pipeline, Development Progress
    • Pipeline by Condition and Therapeutic Area
    • Phase III Development
    • End Users
    • Overview
    • Causes of Cancer Growth
    • Global Cancer Burden
    • Market Outlook
    • Principal Products
    • Trends in Research and Development
    • Market Breakdown of Cell and Gene Therapies
    • Regional Market Summary
    • Competitor Summary
    • Overview
    • Market Outlook
    • Principal Products
    • Trends in Research and Development
    • Market Breakdown of Cell and Gene Therapies
    • Regional Market Summary
    • Competitor Summary
    • Overview
    • Market Outlook
    • Principal Products
    • Trends in Research and Development
    • Market Breakdown of Cell and Gene Therapies
    • Regional Market Summary
    • Competitor Summary
    • Overview
    • Market Outlook
    • Principal Products
    • Market Breakdown of Cell, Gene, and RNA Therapies
    • Regional Market Summary
    • Competitor Summary
    • Overview
    • Market Outlook
    • Principal Products
    • Trends in Research and Development
    • Market Breakdown of Cell and Gene Therapies
    • Regional Market Summary
    • Competitor Summary
    • Overview
    • Market Outlook
    • Principal Products
    • Trends in Research and Development
    • Market Breakdown of Cell and Gene Therapies
    • Regional Market Summary
    • Competitor Summary
    • Market Influences
    • Cell and Gene Therapy and Viral Vector Shortages
    • Global Market Summary
    • Cell vs. Gene Therapy Markets
    • Regional Market Overview
    • North America
    • Europe/European Union
    • Other Countries
    • Competitor Ranking in Cell and Gene Therapy Markets
    • Leading Influencers
    • AlloSource
    • Alnylam Pharmaceuticals, Inc.
    • Amgen
    • AnGes Inc.
    • Anterogen Co Ltd.
    • Atara Biotherapeutics
    • BioCardia
    • Biogen, Inc.
    • BioMarin Pharmaceuticals
    • bluebird bio, Inc.
    • BrainStorm Cell Therapeutics
    • Bristol-Myers Squibb
    • Candel Therapeutics
    • Castle Creek Biosciences
    • Celyad Oncology
    • Cook Myosite, Inc
    • Dendreon Pharmaceuticals (Sanpower)
    • Ferring Pharmaceuticals
    • Gamida Cell Ltd.
    • GenSight Biologics S.A.
    • Gilead Sciences, Inc.
    • Gradalis, Inc
    • Helixmith
    • Inovio Pharmaceuticals, Inc.
    • Medeor Therapeutics
    • MEDIPOST Co, Ltd.
    • MeiraGTx
    • Mesoblast Ltd.
    • Northwest Biotherapeutics, Inc.
    • Novartis AG
    • NuVasive Biologics
    • Orchard Therapeutics
    • Organogenesis
    • Orthofix
    • Osiris Therapeutics, Inc. (Smith & Nephew)
    • Pharmicell
    • Pluristem Therapeutics, Inc.
    • Sangamo Therapeutics
    • Sanofi
    • Sarepta Therapeutics
    • Sotio a.s.
    • Spark Therapeutics
    • uniQure N.V.
    • Vericel Corporation

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us